Teva to get U.S. rights to Andrx products

12/12/2003 | Ha'aretz (Tel Aviv, Israel)

Israel's Teva Pharmaceuticals will get exclusive marketing rights in the U.S. and Canada to Andrx's line of generic oral contraceptive products now awaiting regulatory approval. Financial terms were not disclosed, but analysts said the deal fills holes in Teva's product line and Andrx gets Teva's marketing channels.

View Full Article in:

Ha'aretz (Tel Aviv, Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID